Patrick Zhang

Kimia is a drug discovery company applying high throughput precision chemistry in combination.

Raised $55,000,000.00 from The Column Group, Horizons Ventures and Dimension Capital.

Juvena Therapeutics is a biopharmaceutical platform which is discovering novel protein-based therapeutics.

Raised $49,221,365.00 from Irongrey, Intersect VC, Plum Alley, Karl Pfleger, Horizons Ventures, Transform VC, Alumni Ventures, Felicis, BoxOne Ventures and Jeff Dean.

Manifold Bio is building a protein barcoding platform to bring the power of multiplexed measurement.

Raised $45,399,985.00 from FAST — by GETTYLAB, Tencent, Triatomic Capital, Fifty Years, Section 32, Playground Global, FPV Ventures and Horizons Ventures.

Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform.

Raised $50,000,000.00 from Alta Partners, Venrock and Horizons Ventures.

Concerto Biosciences reinvents humanity's relationship with microbes.

Raised $26,006,949.00 from Springboard Enterprises.

Theradaptive develops targeted therapeutics using its proprietary THX1 platform.

Raised $34,400,000.00 from Maryland Stem Cell Research Fund (MSCRF) and U.S. Department of Defense.